Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03676595
Other study ID # 201308020
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date November 20, 2013
Est. completion date January 2018

Study information

Verified date September 2018
Source Taipei Medical University Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluated the effects of interactive video game-based exercise (IVGB) on balance in diabetic patients with peripheral neuropathy. Twenty-four patients were randomly assigned to two groups (12 participants per group). Group A received IVGB training for the first 6 weeks, with no exercise in the subsequent 6 weeks. Group B had no exercise for the first 6 weeks and then underwent IVGB training in the subsequent 6 weeks. Both subjective and objective measures were used to determine whether IVGB exercise improves balance function.


Description:

Participants in Group A received IVGB intervention for the first 6 weeks (intervention phase), with no exercise in the subsequent 6 weeks (control phase), whereas participants in Group B received no IVGB intervention in the first 6 weeks (control phase), followed by 6 weeks of IVGB intervention (intervention phase). The IVGB intervention protocol consisted of 30-minute training sessions comprising four tasks designed to focus on lower limb strength, balance, and coordination training. Balance assessments consisted of both subjective and objective measures, including the Modified Falls Efficacy Scale (MFES), Time Up and Go (TUG) test, Berg Balance Scale (BBS), and Unipedal Stance Test (UST). For all participants, these tests were conducted at weeks 0, 6, and 12 of the experiment.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date January 2018
Est. primary completion date January 2018
Accepts healthy volunteers No
Gender All
Age group 40 Years to 80 Years
Eligibility Inclusion Criteria:

- 40-80 years of age

- medical diagnoses of diabetes under regular medication control and diabetic peripheral neuropathy confirmed using an electrodiagnostic test

- independent community ambulatory individuals

- intact cognition (Mini-Mental State Examination score of >24).

Exclusion Criteria:

- other neurological diseases such as dementia, Parkinson's disease, spinal cord injury, or stroke;

- severe visual impairment, musculoskeletal disorders, unhealed plantar ulceration, lower limb amputation, poor cardiopulmonary function, or other diseases affecting walking ability or any other disease due to which individuals were unable to walk without assistance

- any other condition associated with a high risk of falling.

- Inability to follow simple instructions

Study Design


Related Conditions & MeSH terms


Intervention

Other:
interactive video game-based exercise
Twenty-four patients were randomly assigned to two groups (12 participants per group). Group A received interactive video game-based exercise training for the first 6 weeks, with no exercise in the subsequent 6 weeks. Group B had no exercise for the first 6 weeks and then underwent interactive video game-based exercise training in the subsequent 6 weeks.
no exercise
Twenty-four patients were randomly assigned to two groups (12 participants per group). Group A received interactive video game-based exercise training for the first 6 weeks, with no exercise in the subsequent 6 weeks. Group B had no exercise for the first 6 weeks and then underwent interactive video game-based exercise training in the subsequent 6 weeks.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Taipei Medical University Hospital

Outcome

Type Measure Description Time frame Safety issue
Primary Change of Berg Balance Scale (BBS) score It consists of 14 functional tasks of varying difficulty, including sitting, standing, changing posture, transfers, reaching forward, retrieving objects, turning, tandem stance, and one-leg stance. It is a valid tool used in both clinical practice and research to evaluate the efficacy of intervention and provide a quantitative description of balance function. The ability to perform each a task is scored on a scale of 0-4, ranging from inability to independently perform the task to successfully completing it, respectively. The maximum possible score for the 14 functional tasks is 56. 15 minutes/session; measured at weeks 0, 6, and 12 of the experiment
Secondary Change of Time Up and Go (TUG) test time Participants stand up from a 46-cm-high armchair with back support, walk straight for 3 m, turn around, walk back to the chair, and sit down as quickly and safely as possible. The timing starts when the investigator says "go" and stops when the participant sits back down on the chair. In our study, each participant had three chances to complete the TUG test in each session, and the best result was recorded for each participant. 5 minutes/session; measured at weeks 0, 6, and 12 of the experiment
Secondary Change of Modified Falls Efficacy Scale (MFES) scores MFES is a 14-item questionnaire related to daily indoor and outdoor physical activities. It is a 10-point visual analog scale of confidence level in completing a particular activity (item) without falling, rated from 0 to 10, where 0 denotes not confident or sure at all, and 10 denotes completely confident or sure. The total score for the 14 items ranges from 0 to 140. 10 minutes/session; measured at weeks 0, 6, and 12 of the experiment
Secondary Change of Unipedal Stance Test (UST) time Participants raised one leg to the ankle level or higher without touching the other leg or using any assistance and then stood on that leg for as long as possible barefoot and with eyes open. The observer measured the length of time for which participants maintained balance; that is, until they were no longer able to keep the leg raised at or above the ankle level or when both legs touched the ground. The observer stopped counting at 45 seconds, recording this as the time for any participant who maintained balance for a longer time. Each participant performed the test three times for both right and left legs, with the best result for each leg recorded. 5 minutes/session; measured at weeks 0, 6, and 12 of the experiment
See also
  Status Clinical Trial Phase
Not yet recruiting NCT05558878 - Effect of Ambroxol in Diabetic Peripheral Neuropathy N/A
Completed NCT03440203 - Prevalence of Peripheral Neuropathy and Its Impact on Activities of Daily Living in Patients With Type 2 Diabetes
Completed NCT03455543 - Dual Field PEMF Therapy in Lower Extremity Painful Diabetic Distal Symmetric Peripheral Neuropathy N/A
Recruiting NCT03725917 - Patients With Diabetic Neuropathy Who Receive Physiotherapy Treatment Will Have a Decrease in Diabetic Foot Ulcers N/A
Enrolling by invitation NCT03907189 - Ambulation as a Factor on Oscillating Thermometry
Completed NCT03888872 - Effect of High Tone Power Therapy on Neurophysiological Measures and Function Outcome in Patients With Diabetic Neuropathy N/A
Withdrawn NCT03354806 - Peripheral Analgesia in Painful Diabetic Neuropathy N/A
Enrolling by invitation NCT05921097 - Comparison of Histamine and Local Heating for Evoking the Axon-reflex Flare Response in Diabetes
Active, not recruiting NCT06463015 - Posterior Tibial Nerve PRF for Diabetic Neuropathic Pain N/A
Completed NCT05299918 - Diabetic Neuropathy Rapid Screening Test in Turkish Patients With Type 2 Diabetes: Sudoscan
Not yet recruiting NCT06201611 - Evaluating a Nitric Oxide Generator, Nebivolol as a Disease Modifier in Patients With Diabetic Neuropathy. Phase 2/Phase 3
Suspended NCT03685253 - Nicotinamide Riboside for Diabetic Neuropathy Phase 1/Phase 2
Completed NCT05977465 - Empagliflozin in Treatment of Peripheral Diabetic Neuropathy Phase 1/Phase 2
Completed NCT03847779 - Microcirculatory Vasomotor Changes in Type 2 Diabetes With Peripheral Neuropathy N/A
Recruiting NCT05642143 - Deep Phenotyping of Bone Disease in Type 2 Diabetes and Relations to Diabetic Neuropathy
Terminated NCT04253860 - Effect of Transcutaneous Electrical Nerve Stimulation in Diabetic Neuropathy Phase 3
Completed NCT03988413 - Study on Safety, Absorption and Metabolism of SYHA1402 Tablets in Healthy People Phase 1
Not yet recruiting NCT05461274 - Determining Patterns In Trial Experiences of Diabetic Neuropathy Patients
Recruiting NCT04841720 - A Study Evaluating Drug-Drug Interaction (DDI) Between HSK16149 Capsules and Metformin Hydrochloride Tablets Phase 1